Industry Collaborations for Biomarker Validation
Industry Collaborations for Biomarker Validation How Industry Collaborations Are Advancing Digital Biomarker Validation Introduction: The Need for Cross-Industry Collaboration Digital biomarkers offer exciting potential for continuous, patient-centric data in clinical trials. However, the path to regulatory acceptance is complex. Unlike traditional biomarkers, digital endpoints often rely on proprietary devices, algorithms, and decentralized capture models. To…
Read More “Industry Collaborations for Biomarker Validation” »